SeaStar Medical Holding Corp (ICU) reports a 45% revenue increase and strategic growth in pediatric hospitals, while addressing trial enrollment challenges and revenue variability.
President Trump announced on Friday that he wanted the Justice Department to investigate high-profile Democrats — including ...
FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval – – $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway – ATLANTA, Nov. 14, ...
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today ...
BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived ...
Q3 2025 Management View Antony Koblish, CEO, emphasized the company's continued execution on expanding its commercial footprint, improving operating discipline, and strengthening its patient-centric ...
Gross profit was $9.3 million, or 88.5% of net revenue, compared to $14.2 million or 77.0% of net revenue in Q3 2024. The increase reflects a product mix shift towards our products that do not carry a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback